Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Sep;9(3):179-85.

A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism

C Amiwero  1 , I A Campbell, R J Prescott
Affiliations
Randomized Controlled Trial

A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism

C Amiwero et al. Afr Health Sci. 2009 Sep.

Abstract

Background: Warfarin is commonly used for management of deep vein thrombosis (DVT) and pulmonary embolism (PE), controlling therapy by means of the International Normalized Ratio (INR).

Objectives: To identify differences in INR results between patients with thromboembolic and haemorrhagic complications and controls.

Methods: Two nested case-control studies from within a controlled trial of the duration of warfarin therapy (47 thrombotic and 16 haemorrhagic complications).

Results: Patients whose thromboembolism failed to resolve during treatment or recurred during or after treatment had non-significantly lower INR levels than matched controls (geometric mean 2.2 versus 2.3, p = 0.12). Patients with haemorrhage also had not statistically significant lower INR levels than their matched controls (2.1 versus 2.3, p = 0.22). The variability of INR levels was similar in both case groups and controls. The mean percentage of INR levels in the therapeutic range 2 - 3 was almost identical in thrombotic cases and controls (56.5% versus 56.1%). Compared to the haemorrhagic group, better control was achieved in controls (61.5% versus 43.0%, p=0.01), but controls had slightly more INR values above the therapeutic range (12.1% versus 10.5%, p = 0.74) whilst haemorrhagic cases had more INR values below the therapeutic range (46.6% versus 26.4%, p = 0.03).

Conclusion: In this study, higher INR levels were not associated with haemorrhage suggesting that, for patients being treated for DVT/PE, a modest increase in the target therapeutic range could be considered.

Keywords: Deep vein thrombosis; Haemorrhage; International normalized ratio; Pulmonary embolism; Thromboembolism; Warfarin; Warfarin Control in treatment of DVT/PE.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustrating the relationship between the standard deviation of the log of INR of clotters and controls
Figure 2
Figure 2
Graph illustrating the relationship between the standard deviation of the log of INR of bleeders and controls
Figure 3
Figure 3
Graph illustrating maximum INR among cases with bleeding complication with the paired controls
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Jones M, McEwan P, Morgan CL, Peters JR, Goodfellow J, Currie CJ. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart. 2005;91(4):472–477. - PMC - PubMed
    1. Lopez JA, Kearon C, Lee YYA. Deep Venous Thrombosis. Haematology. 2004;1:43–49. - PubMed
    1. Jackson MC, Esnouf PM, Lindahl T. A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy. Pathophysiol Haemost Thromb. 2003;33:43–51. Available at http://www.karger.com/pht. - PubMed
    1. Hollowell J, Ruigomez A, Johansson S, Wallander M, Garcia-Rodriquez LA. The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Brit J of Gen Pract. 2003;53:312–314. - PMC - PubMed
    1. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: Clinical epidemiology, Prediction and Prevention. Am J Med. 1993;95:315–328. - PubMed

Publication types

MeSH terms

LinkOut - more resources